218P Peripheral T cell activation phenotype is associated with clinical outcomes and immune-related adverse events of ipilimumab-nivolumab in advanced hepatocellular carcinoma
Won Suk Lee, Hao Yang, Su Jin Lee, So Jung Kong, Beodeul Kang, I. Kim, Heonoh Kim, C. Kim, Hong Jae Chon